Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 633 Posts
1 2 3 ... 40
ETF Battles: Which Biotech Stock ETF Is The Better Choice? - It's IBB Vs. XBI
Video By: Rick Ristov
Thursday, December 23, 2021 6:26 AM EDT
It's ETF Battles time, and in today's episode we'll be comparing the two biotech giants iShares Biotechnology ETF (IBB) Vs. SPDR S&P ETF (XBI).
In this video: IBB, XBI
Watch
Omicron Could Push Up Pfizer’s Share Price By 10% In The Short Term
Article By: Rick Ristov
Wednesday, December 22, 2021 8:02 AM EDT
How the new Omicron Covid variant affects the Pharma/Biotech market and what does this mean for Pfizer/Moderna?
In this article: PFE
Read
4 Top Biotech Stocks To Buy For 2022
Article By: Rick Ristov
Wednesday, December 22, 2021 7:23 AM EDT
Regulatory approvals from FDA and EUA and growing investment and policy support from governments worldwide forecast a bright outlook for the biotech industry in the long run.
In this article: REGN, BIIB, EXEL, UTHR Also: FBT, SPY
Read
Vaccine Stocks: Trading Moderna, Pfizer And Novavax Amid Omicron Outbreak
Article By: Rick Ristov
Tuesday, December 21, 2021 7:12 AM EDT
Amid the new Omicron variant outbreak vaccine providers and their stocks find themselves in the spotlight. Take a look at how these stocks are behaving.
In this article: NVAX, PFA, MRNA Also: JNJ
Read
High Drug Prices And The Refusal To Talk Seriously About Debt And Deficits
Article By: Rick Ristov
Thursday, October 28, 2021 9:17 AM EDT
Reporters and politicians have been screaming about our debt and deficits in recent weeks, as the Democrats try to steer their public investment package through the senators from Arizona and West Virginia.
Read
Biden Wins Election But Trump Refuses To Concede
Article By: Alan Geik
Wednesday, November 11, 2020 12:21 PM EDT
As expected, Biden won the election but my much slimmer margins than anticipated. Complicating matters is Trump's refusal to concede.
In this article: PFE
Read
Cempra Poised To Join Antibacterial Drug Acquisition Rumor Buzz With Upcoming Data Release
Article By: Scott Matusow
Monday, November 24, 2014 12:28 PM EDT
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15. With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.
In this article: CBST, CEMP, TTPH
Read
Shares Of Prosensa Surge 50% After Announcing It Will Be Acquired By Biomarin
Article By: Terry Chrisomalis
Monday, November 24, 2014 10:33 AM EDT
Biomarin is purchasing Prosensa for approximately $840 million.
In this article: BMRN, RNA, SRPT, RGLS
Read
Thanksgiving Top Trades Review – Using Options To Reduce Risk And Increase Profits
Article By: Phil Davis
Saturday, November 22, 2014 1:54 PM EDT
How to use stock options to both leverage AND hedge your positions to maximize your profits while minimizing your risks.
In this article: CAT, CLF, GSK, AAPL, EWJ, TZA, USO
Read
Going Green And Saving Green
Article By: Vivian Lewis
Saturday, November 22, 2014 8:39 AM EDT
Today we consider a way to play cheap fuel prices which directly offsets one of our oil plays. Plus, we plan to take the train. And we report on global energy, pharma and food stock happenings.
In this article: AGU, CPA, EC, NBL, NOK, NVS, POT, SLB, ATONY, BRGYY, DGRLY, TKPPY, ILMN, MHG, CGG
Read
Special Report: Benitec Biopharma Ltd.
Article By: Vivian Lewis
Thursday, November 20, 2014 8:41 AM EDT
This special report is about Benitec, a stock we recommend, after I spent the morning at its US Investor Day.
In this article: BTEBY
Read
AGIO Hits Record Level On Impressive Clinical Data For Leukemia Drug
Article By: BioMedReports
Thursday, November 20, 2014 3:21 AM EDT
Shares of Agios Pharmaceuticals Inc. posted its biggest single day rally on Wednesday since 26th September. The stock is up a whopping 15% to $96.25 after hitting an all time high of $96.88 earlier in the session.
In this article: AGIO
Read
Merrimack Receives Fast Track For Pancreatic Cancer Drug
Article By: Terry Chrisomalis
Wednesday, November 19, 2014 4:29 PM EDT
The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.
In this article: BAX, MACK
Read
Health Care REIT Completes HealthLease Transaction
Article By: Business Wire
Wednesday, November 19, 2014 12:00 PM EDT
Health Care REIT, Inc. announced today the completion of the previously announced acquisition of HealthLease Properties REIT (“HealthLease”).
In this article: HCN
Read
CytRx Announces Partial Clinical Hold On Main Drug' Big Buying Opportunity For Investors
Article By: Terry Chrisomalis
Tuesday, November 18, 2014 2:36 PM EDT
Aldoxorubicin receives a partial clinical hold from the FDA.
In this article: CYTR
Read
Fat Busting By Injection
Article By: IPO Candy
Tuesday, November 18, 2014 1:42 PM EDT
Neothetics is on the road now to fund the continued development of their injection-based approach to fat loss. It’s a smallish deal of $4.3M shares, with a $13-15 price range.
In this article: ZLTQ, KYTH
Read
1 to 16 of 633 Posts
1 2 3 ... 40